logo
Select company
Select metric
$ 224KNet Cash Flow - Financing
VS
Market
46
Sector
68
Industry
80
History
67
$ 2.09Close
$ 0.99 - $ 4.47 52-Week Range
Ticker Information

Ticker

MURA

Company Name

MURAL ONCOLOGY PLC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

MURAL ONCOLOGY PLC - Net Cash Flow - Financing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

MURA - CF - Financing Historical data
DateNet Cash Flow - Financing
6/30/2025$ 224K
3/31/2025$ 224K
12/31/2024$ 196K
9/30/2024$ 315.21M
6/30/2024$ 366.65M
12/31/2023$ 468.81M
12/31/2022$ 174.1M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • MURAL ONCOLOGY PLC's latest trailing twelve months (TTM) CF - Financing stands at $ 174.1M.
  • Over the past 5 years, MURAL ONCOLOGY PLC's average CF - Financing has been $ 189.34M.
  • The median CF - Financing for MURAL ONCOLOGY PLC during this period was $ 174.1M
  • MURAL ONCOLOGY PLC reached its highest CF - Financing over the past 5 years at $ 468.81M.
  • The lowest CF - Financing recorded by MURAL ONCOLOGY PLC in the same timeframe $ 196K

Definition of Net Cash Flow - Financing

[Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.

MURA - Net Cash Flow - Financing, Last 5 years

$ 196K

Minimum

Dec 31, 2024

$ 468.81M

Maximum

Dec 31, 2023

$ 189.34M

Average

$ 174.1M

Median

CF - Financing Benchmark Analysis

The chart above depicts the distribution of CF - Financing for companies in the Total Stock Market. The average CF - Financing of the companies is $ -6.85M with a standard deviation of $ 119.31M.
The following table provides additional summary stats:
CF - Financing in the Market:
filtered constituents3.22K
min$ -367.1M
max$ 366M
average$ -6.85M
median$ 305K
std$ 119.31M